Amphastar Pharmaceuticals
AMPH
AMPH
277 hedge funds and large institutions have $1.71B invested in Amphastar Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 99 increasing their positions, 93 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 268 → 277 (+9)
2.29% more ownership
Funds ownership: 70.34% → 72.62% (+2.3%)
6% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 93
Holders
277
Holding in Top 10
3
Calls
$3.91M
Puts
$1.12M
Top Buyers
| 1 | +$26.2M | |
| 2 | +$21.3M | |
| 3 | +$16.6M | |
| 4 |
Goldman Sachs
New York
|
+$14.4M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$10.8M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$9.56M | |
| 3 | -$8.66M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.21M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.73M |